DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System decreased its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating) by 2.8% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 397,001 shares of the medical instruments supplier’s stock after selling 11,480 shares during the period. California Public Employees Retirement System owned 0.18% of DENTSPLY SIRONA worth $14,185,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of XRAY. Nuance Investments LLC increased its position in DENTSPLY SIRONA by 356.3% during the second quarter. Nuance Investments LLC now owns 9,051,338 shares of the medical instruments supplier’s stock worth $323,404,000 after purchasing an additional 7,067,751 shares during the last quarter. BlackRock Inc. grew its stake in DENTSPLY SIRONA by 36.1% during the first quarter. BlackRock Inc. now owns 24,083,158 shares of the medical instruments supplier’s stock worth $1,185,372,000 after buying an additional 6,382,605 shares during the period. Wellington Management Group LLP grew its stake in DENTSPLY SIRONA by 83.1% during the first quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock worth $270,829,000 after buying an additional 2,497,773 shares during the period. Lazard Asset Management LLC grew its stake in DENTSPLY SIRONA by 11,805,127.3% during the second quarter. Lazard Asset Management LLC now owns 1,298,575 shares of the medical instruments supplier’s stock worth $46,397,000 after buying an additional 1,298,564 shares during the period. Finally, American Century Companies Inc. grew its stake in DENTSPLY SIRONA by 8,220.9% during the first quarter. American Century Companies Inc. now owns 1,292,987 shares of the medical instruments supplier’s stock worth $63,641,000 after buying an additional 1,277,448 shares during the period. Institutional investors and hedge funds own 96.00% of the company’s stock.

DENTSPLY SIRONA Stock Performance

NASDAQ:XRAY opened at $31.13 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.50 and a quick ratio of 1.05. DENTSPLY SIRONA Inc. has a 1-year low of $26.48 and a 1-year high of $58.70. The firm has a 50-day moving average of $29.91 and a two-hundred day moving average of $34.15. The stock has a market cap of $6.69 billion, a P/E ratio of 11.66, a PEG ratio of 4.04 and a beta of 0.95.

DENTSPLY SIRONA (NASDAQ:XRAYGet Rating) last issued its quarterly earnings results on Monday, November 14th. The medical instruments supplier reported $0.41 EPS for the quarter, missing the consensus estimate of $0.59 by ($0.18). DENTSPLY SIRONA had a positive return on equity of 9.63% and a negative net margin of 20.81%. The company had revenue of $947.00 million for the quarter, compared to the consensus estimate of $1.01 billion. During the same period in the previous year, the business posted $0.68 EPS. The business’s revenue for the quarter was down 8.9% on a year-over-year basis. On average, research analysts expect that DENTSPLY SIRONA Inc. will post 1.96 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. Evercore ISI boosted their price objective on shares of DENTSPLY SIRONA to $34.00 in a research note on Thursday. TheStreet downgraded shares of DENTSPLY SIRONA from a “c” rating to a “d” rating in a research note on Monday, November 14th. UBS Group decreased their price objective on shares of DENTSPLY SIRONA to $35.00 in a research note on Thursday. The Goldman Sachs Group decreased their target price on shares of DENTSPLY SIRONA from $41.00 to $34.00 and set a “neutral” rating for the company in a research note on Wednesday. Finally, Barrington Research dropped their price target on shares of DENTSPLY SIRONA from $51.00 to $40.00 in a research note on Tuesday, November 15th. One analyst has rated the stock with a sell rating, six have issued a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of “Hold” and a consensus target price of $40.70.

DENTSPLY SIRONA Profile

(Get Rating)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies for professional dental market worldwide. The company operates through two segments, Technologies & Equipment, and Consumables. The Technologies & Equipment segment provides dental equipment, such as treatment centers, imaging equipment, motorized dental handpieces, and other instruments for dental practitioners and specialists; dental CAD/CAM technologies for dental offices to support various digital dental procedures, including dental restorations; dentist-directed clear aligner solutions, SureSmile, and direct-to-consumer clear aligner solutions, as well as high frequency vibration technology device; implants; and urology catheters and other healthcare-related consumable products.

Further Reading

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYGet Rating).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.